...
首页> 外文期刊>Acta biomaterialia >Nanostructured mucoadhesive microparticles for enhanced preocular retention
【24h】

Nanostructured mucoadhesive microparticles for enhanced preocular retention

机译:纳米结构的粘膜粘附微粒可增强眼前保留

获取原文
获取原文并翻译 | 示例

摘要

We describe nanostructured microparticles (NMs) containing a mucoadhesive polymer for enhanced preocular retention and consider them as potential carriers of drugs to the eye. These NMs are each composed of entangled nanofibers to give an enlarged specific surface area, and thus can better adhere to the preocular mucus surface. This physical design allows the microparticles still to be composed mainly of a wall material, poly(lactic-co-glycolic acid), as required for controlled drug delivery, while the effects of an additive, mucoadhesive material, polyethylene glycol, can be synergistically improved via the nanostructured morphology. Thus, when formulated in a dry tablet dosage form, the NMs in this work show more than a 10-fold increase in preocular retention in vivo compared to conventional spherical microparticles. Therefore, we conclude that these mucoadhesive NMs can reside on the preocular surface for a prolonged period, and thus appear to be a promising system for topical drug delivery to the eye.
机译:我们描述了包含粘膜粘附性聚合物以增强眼前保留的纳米结构微粒(NMs),并将其视为药物对眼睛的潜在载体。这些NM均由缠结的纳米纤维组成,以提供更大的比表面积,因此可以更好地粘附至眼前粘液表面。这种物理设计可以使微粒仍然主要由壁材料聚乳酸-乙醇酸组成,这是控制药物输送所需的,同时可以协同改善添加剂,粘膜粘附材料聚乙二醇的作用通过纳米结构形态。因此,当以干燥的片剂剂型配制时,与常规的球形微粒相比,这项工作中的NMs在体内的眼前滞留性增加了10倍以上。因此,我们得出的结论是,这些粘膜粘附性NMs可以长时间停留在眼前表面上,因此似乎是将局部药物递送至眼睛的有希望的系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号